Stay updated on Sotatercept in PAH: New Intermediate-High Risk Clinical Trial
Sign up to get notified when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.

Latest updates to the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page
- CheckyesterdayChange DetectedNo additions or deletions were detected between the two screenshots; the page content and layout appear unchanged.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2 on the page.SummaryDifference0.1%

- Check15 days agoChange DetectedPublications section updated to clarify that PubMed entries are auto-filled and may not be about the study; revision number updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check23 days agoChange DetectedThe Tainan location entry is updated from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704' to reflect the corrected city designation.SummaryDifference0.2%

- Check30 days agoChange DetectedNo significant changes detected in the Study Details page for NCT04811092. The content and layout appear consistent with the registered record, including trial title, study design, and eligibility criteria.SummaryDifference0.0%

- Check37 days agoChange DetectedPublications section updated: added the NEJM paper 'Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis' (N Engl J Med. 2025 Oct 23; 393(16):1599-1611). The online-ahead-of-print listing dated Sep 30, 2025 was removed.SummaryDifference0.2%

Stay in the know with updates to Sotatercept in PAH: New Intermediate-High Risk Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.